Leslie Bottorff joined ONSET Ventures in 1998 after 19 years in the medical industry.
At ONSET Ventures, Leslie specializes in medical technology investment opportunities.
She has worked closely with several portfolio company entrepreneurs at the seed stage to formulate and validate their companies’ business plans, including Embolic Protection, where she was interim VP of Marketing and Business Development at inception.
Leslie was the original seed investor in Sadra Medical (acquired by Boston Scientific in 2011) and has served on the board for several portfolio companies including Sadra Medical, Spinal Concepts, VisionCare Ophthalmic Technologies, Neuronetics, Flexuspine, Relievant and CytoPherx.
Prior to joining ONSET, Leslie was VP of Sales and Marketing of Medtronic’s CardioRhythm division.
She has also served in various marketing and sales management positions at both venture backed start-up companies and in large companies, including Nellcor, Ventritex, Menlo Care and General Electric’s Medical Systems division.
Leslie has a B.S. in Biomedical Engineering from Purdue University and an MBA from Harvard Business School.
She serves on advisory boards or as program faculty at several universities, including Stanford University and Purdue University.
|Apr, 2015||Neuronetics||$34.3M / Series F (Lead)||GE Ventures|
|Jan, 2012||CytoPherx||$34M / Series C (Lead)||ONSET Ventures|
|May, 2011||Neuronetics||$30M / Series E||ONSET Ventures|
|Oct, 2009||Neuronetics||$30M / Series D||ONSET Ventures|
|May, 2009||Sadra Medical||$30M / Series C||ONSET Ventures|
|Jan, 2008||Aragon Surgical||$25M / Series B||ONSET Ventures|
|May, 2007||Pegasus Biologics||$20M / Series C (Lead)||ONSET Ventures|
|Oct, 2006||Sadra Medical||$19M / Series B (Lead)||ONSET Ventures|
|Jun, 2004||Sadra Medical||$9M / Series A||ONSET Ventures|
|Oct 13, 2016||PRNewswire All - Iora Health Raises $75 Million Series D Financing|
|Jul 21, 2016||PRWeb Sitemap - Silicon Valley Boomer Venture Summit Names Noctrix Health the 2016 Business Plan Competition Winner|
|May 10, 2007||Venture Beat - Pegasus Bio gets $20M for surgical-repair bioimplants|